Skip to main content
. 2017 Jul 18;3(4):332–335. doi: 10.1016/j.jdcr.2017.05.006

Fig 1.

Fig 1

A, Prominent facial edematous erythema of patient at initial presentation. B, Resolution of the rash and swelling over the face after TNF-α inhibitor treatment.